Surveys in secondary analysis of NCD medicine availability and affordability.

<p>Surveys in secondary analysis of NCD medicine availability and affordability.</p

Percentage of data points where medicines were both available and affordable, by World Bank Income Group.

<p>Percentage of data points where medicines were both available and affordable, by World Bank Income Group.</p

Median percentage availability by World Bank Income Group.

<p>Median percentage availability by World Bank Income Group.</p

Median number of days’ wages needed to purchase standard treatments, by World Bank Income Group.

<p>Median number of days’ wages needed to purchase standard treatments, by World Bank Income Group.</p

Percentage cause of not meeting the WHO target (poor availability, poor affordability, or both).

<p>Percentage cause of not meeting the WHO target (poor availability, poor affordability, or both).</p

Availability and affordability of metformin 500mg and 850mg tabs, lowest priced generics, by sector and country.

<p>AF Afghanistan, BI Burundi, BO Bolivia, BR Brazil Rio Grande de Sol, CH China Shaanxi Province, CO Colombia, EC Ecuador, ID Indonesia, IN India Delhi, IR Iran, KG Kyrgyzstan, LA Lao PDR, LE Lebanon, MA Mauritius, ME Mexico City, MO Mongolia, SU Sudan, TA Tanzania, TJ Tajikistan, UG Uganda, UK Ukraine. Note: medicines in the public sector in BR, EC, ME, IN, UG, CO, LE and MA were dispensed free-of-charge to all patients in the outlets sampled so days’ wages are indicated as 0.</p

Additional file 1: of Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology

Supplementary details on survey methods, data and statistical analyses. (PDF 874 kb

ジョン・デューイはどうして宗教哲学者なのか――アメリカ哲学における宗教・政治・消費という論点をめぐって――

京都大学0048新制・課程博士博士(人間・環境学)甲第22527号人博第930号新制||人||222(附属図書館)2019||人博||930(吉田南総合図書館)京都大学大学院人間・環境学研究科共生人間学専攻(主査)教授 戸田 剛文, 教授 佐藤 義之, 教授 安部 浩, 准教授 青山 拓央学位規則第4条第1項該当Doctor of Human and Environmental StudiesKyoto UniversityDGA

Principal component analysis scores plots highlighting the metabolic separation of the DBD and DCD grafts in the cold phase (T₁) and separately the post-reperfusion phase (T₂), based on analyses of just the 50 and 64 peaks identified as being significantly different (between DBD and DCD) for the T₁ and T₂ groups, respectively.

<p>Variance explained for T₁, PC1 = 36.75% and PC2 = 19.39% and for T₂, PC1 = 25.22% and PC2 = 17.41%.</p

The differences between tryptophan and kynurenine in failed allografts due to Primary non-function/PNF (n = 2) vs. non-PNF (n = 36) in the cold phase and post reperfusion.

<p>The data show the relative abundances of the metabolites with 95% confidence intervals (statistics not applied due to limited sample size).</p